Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data

Introduction: Phytopharmaceutical products are successfully used for acute respiratory infections and may therefore be promising candidates for adjuvant symptomatic treatment of COVID-19. In vitro and clinical studies suggest that the proprietary Pelargonium sidoides DC. root extract EPs 7630 has an...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Fathi Abdul Malek, Petra Funk
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-02-01
Edice:	Frontiers in Pharmacology
Témata:	Pelargonium sidoides root extract (EPs 7630) off-label use case reports COVID-19 spontaneous reporting safety
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1335309/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!